Botanical species · safety record

Anchusa officinalis

The EFSA Compendium of Botanicals holds 5 constituent measurements for Anchusa officinalis. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Anchusa officinalis L.

5Constituent measurements
0Safety records
4Cited sources
0Licensed products (Canada)

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

  • Pentacyclic triterpene saponins2
  • Laburnine1
  • Lycopsamine1
  • Pyrrolizidine alkaloids1

Plant parts

  • Aerial part of plants2
  • Roots and other underground parts1
  • Seed1
  • Unspecified1

Preparations

  • Solvent extraction5

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
LaburnineSeedSolvent extractionGC-MS (Q)Resolve DOI
LycopsamineRoots and other underground partsSolvent extractionStandard Chromatographic tests (paper- thin layer- and column chromatography)Resolve DOI
Pentacyclic triterpene saponinsAerial part of plantsSolvent extractionStandard Chromatographic tests (paper- thin layer- and column chromatography)Resolve DOI
Pentacyclic triterpene saponinsAerial part of plantsSolvent extractionStandard Chromatographic tests (paper- thin layer- and column chromatography)No resolvable identifier
Pyrrolizidine alkaloidsUnspecifiedSolvent extractionGC-MSNo resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Huizing, H. J., De Boer, F., Hendriks, H., Balraadjsing, W., Bruins, A. P. Positive and negative ion chemical ionization mass spectrometry of trimethylsilyl derivatives of pyrrolizidine alkaloids using amine radical and hydroxide as the reactant ions. Biomedical & environmental mass spectrometry, 1986, vol. 13, no. 6, p. 293-8.
  2. BROCHDUE, AI., AASEN, AJ. ALKALOIDS OF ANCHUSA-OFFICINALIS L IDENTIFICATION OF THE PYRROLIZIDINE ALKALOID LYCOPSAMINE . Acta chemica scandinavica series b-organic chemistry and biochemistry, 1980, vol. 34, no. 1, p. 75-77. DOI
  3. Romussi, G., Falsone, G., Wendisch, D., Parodi, B. Inhaltsstoffe von Boraginaceae, 7. Anchusosid-8 und -9: Zwei neue Triterpensaponine aus Anchusa officinalis L.. Liebigs annalen der chemie, 1984, vol. 1984, no. 11, p. 1869-1872. DOI
  4. Romussi, Giovanni., Ciarallo, Giovanni., Falsone, Gioacchino., Schneider, Claudia. Constituents of Boraginaceae. Triterpene saponins from Anchusa officinalis. Liebigs annalen der chemie, 1979, vol. (12), p. 2028-35.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue